Browsing by Subject "Renal Insufficiency, Chronic"

-572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease

Panayides A., Ioakeimidou A., Karamouzos V., Antonakos N., Koutelidakis I., Giannikopoulos G., Makaritsis K., Voloudakis N., Toutouzas K., Rovina N., Bristianou M., Damoraki G., Routsi C., Giamarellos-Bourboulis E.J. (2015)

Single nucleotide polymorphisms (SNPs) of interleukin (IL)-6 are associated with the development of chronic renal disease (CRD). Their impact for sepsis in the field of CRD was investigated. One control cohort of 115 ...

B12 deficiency in chronic kidney disease: Early recognition matters

Gavriilaki E., Paschou E., Kalaitzoglou A., Papaioannou G., Sabanis N. (2015)

[No abstract available]

Cardiac autonomic function during intradialytic exercise training

Kaltsatou A., Hadjigeorgiou G.M., Grigoriou S.S., Karatzaferi C., Giannaki C.D., Lavdas E., Fotiou D., Kouidi E., Patramani G., Vogiatzi C., Pappas A., Stefanidis I., Sakkas G.K. (2019)

Objectives: Cardiac autonomic nervous system (ANS) dysfunction is a common feature in patients receiving hemodialysis (HD) therapy, whilst is associated with an increased risk of ventricular arrhythmias and sudden cardiac ...

Dietary antioxidant supplements and uric acid in chronic kidney disease: A review

Roumeliotis S., Roumeliotis A., Dounousi E., Eleftheriadis T., Liakopoulos V. (2019)

Increased serum levels of uric acid have been associated with the onset and development of chronic kidney disease (CKD), cardiovascular disease, and mortality, through several molecular pathogenetic mechanisms, such as ...

Evaluation of serum symmetric dimethylarginine as a biomarker of kidney disease in canine leishmaniosis due to Leishmania infantum

Giapitzoglou S., Saridomichelakis M.N., Leontides L.S., Kasabalis D., Chatzis M., Apostolidis K., Theodorou K., Roumpeas E., Mylonakis M.E. (2020)

Canine leishmaniosis (CanL)-associated chronic kidney disease is a leading cause of morbidity and mortality in Mediterranean countries. Novel renal biomarkers, such as serum symmetric dimethylarginine (sSDMA), may be useful ...

Glucose Derivative Induced Vasculopathy in Children on Chronic Peritoneal Dialysis

Bartosova M., Zhang C., Schaefer B., Herzog R., Ridinger D., Damgov I., Levai E., Marinovic I., Eckert C., Romero P., Sallay P., Ujszaszi A., Unterwurzacher M., Wagner A., Hildenbrand G., Warady B.A., Schaefer F., Zarogiannis S.G., Kratochwill K., Schmitt C.P. (2021)

RATIONALE: Patients with chronic kidney disease (CKD) have an exceedingly high cardiovascular risk; which further increases in patients on peritoneal dialysis (PD). The pathophysiological role of reactive metabolites ...

Histology and immunohistochemistry of radial arteries are suggestive of an interaction between calcification and early atherosclerotic lesions in chronic kidney disease

Lysitska A., Galanis N., Skandalos I., Nikolaidou C., Briza S., Fylaktou A., Lioulios G., Mitsoglou Z., Papadopoulou D., Antoniadis N., Papagianni A., Stangou M. (2021)

Background and Objectives: recent studies suggest an implication of immune mechanisms in atherosclerotic disease. In this paper, the interaction between inflammation, calcification, and atherosclerosis on the vessel walls ...

Hypertension in chronic kidney disease: Novel insights

Duni A., Dounousi E., Pavlakou P., Eleftheriadis T., Liakopoulos V. (2020)

Management of arterial hypertension in patients with chronic kidney disease (CKD) remains a major challenge due to its high prevalence and associations with cardiovascular disease (CVD) and CKD progression. Several clinical ...

Intra-renal hemodynamic changes after habitual physical activity in patients with chronic kidney disease

Kaltsatou A., Karatzaferi C., Mitrou G.I., Poulianiti K.P., Sakkas G.K. (2016)

Background: Chronic Kidney Disease (CKD) is considered a silent epidemic with a continuously growing prevalence around the world. Due to uremia many functional and morphological abnormalities occur in almost all systems. ...

Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis

Tziastoudi M., Theoharides T.C., Nikolaou E., Efthymiadi M., Eleftheriadis T., Stefanidis I. (2022)

Renal fibrosis (RF) constitutes the common end-point of all kinds of chronic kidney disease (CKD), regardless of the initial cause of disease. The aim of the present study was to identify the key players of fibrosis in the ...

Management of blood pressure and heart rate in chronic kidney disease

Kaltsatou A. (2017)

Background: Hypertension is considered a major health problem in patients with chronic kidney disease (CKD) as approximately 80-85% of CKD patients’ suffer from hypertension in the United States. Hypertension is the second ...

Novel Therapeutic Strategies for Cardiorenal Protection in Patients with Type 2 Diabetes and Chronic Kidney Disease

Georgianos P.I., Roumeliotis S., Eleftheriadis T., Liakopoulos V. (2022)

Type 2 diabetes mellitus (T2DM) is the leading cause of end-stage kidney disease (ESKD) worldwide [1]. The development of chronic kidney disease (CKD) in patients with T2DM sub-stantially increases their risk for cardiovascular ...

On the increased event rate of urinary tract infection and pneumonia in CKD patients treated with roxadustat for anemia

Eleftheriadis T., Pissas G., Liakopoulos V., Stefanidis I. (2021)

[No abstract available]

Oxidative stress in the critically ill patients: Pathophysiology and potential interventions

Makris D., Mertens P.R., Dounousi E., Giamouzis G., Nseir S. (2018)

[No abstract available]

Quality of Life of Hemodialysis Patients in Greece: Associations with Socio-Economic, Anthropometric and Nutritional Factors

Floria I., Kontele I., Grammatikopoulou M.G., Sergentanis T.N., Vassilakou T. (2022)

Chronic kidney disease (CKD) is a serious public health problem that, in recent decades, has taken on significant dimensions with serious effects on the quality of life (QoL) of patients. The purpose of this cross-sectional ...

Renal function and risk stratification of patients with embolic stroke of undetermined source

Ntaios G., Lip G.Y.H., Lambrou D., Michel P., Perlepe K., Eskandari A., Nannoni S., Sirimarco G., Strambo D., Vemmos K., Koroboki E., Manios E., Vemmou A., Rodríguez-Campello A., Cuadrado-Godia E., Roquer J., Arnao V., Caso V., Paciaroni M., Diez-Tejedor E., Fuentes B., Pardo J.R., Arauz A., Ameriso S.F., Pertierra L., Gómez-Schneider M., Hawkes M.A., Bandini F., Cano B.C., Mohedano A.M.I., Pastor A.G., Gil-Núñez A., Putaala J., Tatlisumak T., Barboza M.A., Karagkiozi E., Makaritsis K., Papavasileiou V. (2018)

Background and Purpose-We aimed to assess if renal function can aid in risk stratification for ischemic stroke or transient ischemic attack (TIA) recurrence and death in patients with embolic stroke of undetermined source ...

Serum feline pancreatic lipase immunoreactivity and trypsin-like immunoreactivity concentrations in cats with experimentally induced chronic kidney disease

Xenoulis P.G., Moraiti K.T., R. Finco D., Suchodolski J.S., Steiner J.M. (2021)

Background: Serum feline pancreatic lipase immunoreactivity (fPLI) and trypsin-like immunoreactivity (fTLI) concentrations are commonly used in cats for the evaluation of pancreatic disease. The effect of kidney disease ...

Serum α1-proteinase inhibitor concentrations in dogs with exocrine pancreatic disease, chronic hepatitis or proteinuric chronic kidney disease

Heilmann R.M., Grützner N., Hokamp J.A., Lidbury J.A., Xenoulis P.G., Suchodolski J.S., Nabity M.B., Cianciolo R., Steiner J.M. (2018)

Serum canine α1-proteinase inhibitor (cα1-PI) concentrations were evaluated in dogs with pancreatitis (n = 24), exocrine pancreatic insufficiency (EPI; n = 29), chronic hepatitis (CH; n = 11) or proteinuric chronic kidney ...

A systematic review and meta-analysis of pharmacogenetic studies in patients with chronic kidney disease

Tziastoudi M., Pissas G., Raptis G., Cholevas C., Eleftheriadis T., Dounousi E., Stefanidis I., Theoharides T.C. (2021)

Chronic kidney disease (CKD) is an important global public health problem due to its high prevalence and morbidity. Although the treatment of nephrology patients has changed considerably, ineffectiveness and side effects ...

Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review

Poulianiti K.P., Kaltsatou A., Mitrou G.I., Jamurtas A.Z., Koutedakis Y., Maridaki M., Stefanidis I., Sakkas G.K., Karatzaferi C. (2016)

Patients with chronic kidney disease (CKD) experience imbalance between oxygen reactive species (ROS) production and antioxidant defenses leading to cell and tissue damage. However, it remains unclear at which stage of ...